Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GENEREX BIOTECHNOLOGY CORP (GNBT)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jul-31-20 | Jul-31-19 | Jul-31-18 | Jul-31-17 | Jul-31-16 | Jul-31-15 | Jul-31-14 | Jul-31-13 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | | 100.0% | 100.0% | | |
| Cost of goods sold | 21.8% | 66.7% | 0.0% | | 0.0% | 100.0% | | |
| Gross profit | 78.2% | 33.3% | 100.0% | | 100.0% | 0.0% | | |
| Research and development | 79.1% | 28.2% | 119.3% | | 15.2% | | | |
| General and administrative | 672.5% | 345.1% | 335.5% | | 46.8% | 200.6% | | |
| Depreciation | 31.2% | 6.9% | 3.4% | | 8.6% | 32.1% | | |
| EBIT | -638.2% | -397.1% | -354.9% | | -24.0% | -300.6% | | |
| Pre-tax income | -1286.2% | -177.4% | 5111.8% | | -105.0% | -185.0% | | |
| Income taxes | 0.0% | 0.0% | 0.0% | | 0.0% | 0.0% | | |
| Net income | -1252.5% | -150.6% | 5166.6% | | -105.0% | -213.7% | | |
|